Advertisement

Lung

, Volume 195, Issue 5, pp 671–677 | Cite as

First Identification of Pulmonary Asbestos Fibres in a Spanish Population

  • M. I. Velasco-García
  • M. J. Cruz
  • C. Diego
  • M. A. Montero
  • D. Álvarez-Simón
  • J. Ferrer
Article

Abstract

Introduction

This study aimed to characterize, for the first time in Spain, the type of asbestos fibres (AF) in the lungs of exposed and non-exposed populations.

Materials and Methods

Lung samples from 38 subjects living in Barcelona and Ferrol, Spain, were studied, which were divided into three groups: Group A—five subjects without known respiratory disease; Group B—20 ex-shipyard workers and Group C—13 patients with lung cancer. After eliminating the organic material, the inorganic residue was analysed using electronic microscopy (EM). To identify the type of fibre, the samples were analysed by scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDX).

Results

All the fibres identified corresponded to amphiboles (crocidolite 45%, anthophyllite 22%, tremolite 16%, amosite 15% and actinolite 3%). In 14 patients (37%), a single type of asbestos was found in the lungs (amosite in two, actinolite in one, anthophyllite in four, crocidolite in five and tremolite in two). Forty-six percent of the AF analysed had a length > 5 µm and a diameter < 0.2 µm.

Conclusions

The results of this study provide the first data on the type of asbestos retained in the lung of Spanish population. A particularly striking finding is the exclusive retention of amphiboles, which suggests that chrysotile is eliminated after inhalation. Our findings support estimations considering Spain and other southern European countries with similar asbestos imports and consumption at a high risk to develop asbestos-related diseases in the years to come.

Keywords

Asbestos bodies Lung cancer Asbestos fibres 

Notes

Acknowledgements

This Project was supported by the Fis PI07/90478 (Instituto de Salud Carlos III, Madrid), Fondo Europeo de Desarrollo Regional (FEDER), Fundació Catalana de Pneumologia (FUCAP) and Sociedad Española de Patología Respiratoria (SEPAR). MJC is a researcher supported by the Miguel Servet programme from Instituto de Salud Carlos III (CP12/03101).

Compliance with Ethical Standards

Conflict of interest

None.

References

  1. 1.
    Becklake MR, Bagatin E, Neder JA (2007) Asbestos-related diseases of the lungs and pleura: uses, trends and management over the last century. Int J Tuberc Lung Dis 11:356–369PubMedGoogle Scholar
  2. 2.
    Mossman BT, Lippmann M, Hesterberg TW, Kelsey KT, Barchowsky A, Bonner JC (2011) Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J Toxicol Environ Health B Crit Rev 14(1–4):76–121CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Nielsen LS, Bælum J, Rasmussen J, Dahl S, Olsen KE, Albin M et al (2014) Occupational asbestos exposure and lung cancer–a systematic review of the literature. Arch Environ Occup Health 69(4):191–206CrossRefPubMedGoogle Scholar
  4. 4.
    Prospection on the presence of asbestos or materials that contain it in buildings. Practical identification of asbestos and methodology of analysis. Association of quantity surveyors and architects of Barcelona and National Institute of security and work health (2003) Institute for studies in security. Foundation for the prevention of occupational risk, BarcelonaGoogle Scholar
  5. 5.
    López-Abente G, García-Gómez M, Menéndez-Navarro A, Fernández-Navarro P, Ramis R, García-Pérez J et al (2013) Pleural cancer mortality in Spain: time-trends and updating of predictions up to 2020. BMC Cancer 13:528CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Orriols R, Costa R, Albanell M, Alberti C, Castejon J, Monso E et al (2006) Malaltia Ocupacional Respiratória (MOR) Group. Reported occupational respiratory diseases in Catalonia. Occup Environ Med 63:255–260CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Finish Institute of Occupational Health (1997) Asbestos, Asbestosis and Cancer. Proceedings of an International Expert Meeting. HelsinkiGoogle Scholar
  8. 8.
    De Vuyst P, Karjalainen A, Dumortier P, Pairon JC, Monsó E, Brochard P, Teschler H et al (1998) Guidelines for mineral fibre analyses in biological simples: report of the ERS Working Group. Eur Respir J 11:1416–1426CrossRefPubMedGoogle Scholar
  9. 9.
    Churg A (1994) Deposition and clearance of chrysotile asbestos. Ann Occup Hyg 38:625–633PubMedGoogle Scholar
  10. 10.
    Dodson D, Hammar SP (2004) Quantitative analysis of asbestos burden in a series of individuals with lung cancer and a history of exposure to asbestos. Inhal Toxicol 16:637–647CrossRefPubMedGoogle Scholar
  11. 11.
    Fondimare A, Desbordes J (1974) Asbestos bodies and fibres in lung tissues. Environ Health Perspect 9:147–148PubMedPubMedCentralGoogle Scholar
  12. 12.
    Casali C, Carugno M, Cattaneo A, Consonni D, Mensi C, Genovese U et al (2015) Asbestos lung burden in necropsic samples from the general population of Milan, Italy. Ann Occup Hyg 59(7):909–921CrossRefPubMedGoogle Scholar
  13. 13.
    Paoletti L, Falchi M, Batisti M, Carrieri P, Petrelli MG, Ciacella C et al (1991) Mineral lung burden of an urban population. Atmos Environ 25:381–385CrossRefGoogle Scholar
  14. 14.
    Magnani C, Mollo F, Paoletti L, Bellis D, Bernardi P, Betta P et al (1998) Asbestos lung burden and asbestosis after occupational and environmental exposure in an asbestos cement manufacturing area: a necropsy study. Occup Environ Med 55:840–846CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Monsó E, Teixidó A, Lopez D, Aguilar X, Fiz J, Ruiz J et al (1995) Asbestos bodies in normal lung of western Mediterranean populations with no occupational exposure to inorganic dust. Arch Environ Health 50(4):305–311CrossRefPubMedGoogle Scholar
  16. 16.
    Velasco-García MI, Recuero R, Cruz MJ, Panades R, Martí G, Ferrer J (2010) Prevalence and distribution of asbestos lung residue in a Spanish urban population. Arch Bronconeumol 46(4):176–181CrossRefPubMedGoogle Scholar
  17. 17.
    Diego C, Velasco-García MI, Cruz MJ, Untoria MD, Morell F, Ferrer J (2013) Contenido pulmonar de amianto en trabajadores de los astilleros de Ferrol. Med Clin (Barc) 140(4):152–156CrossRefGoogle Scholar
  18. 18.
    Finkelstein MM, Dufresne A (1999) Inferences on the kinetics of asbestos deposition and clearance among chrysotile miners and millers. Am J Ind Med. 35:401–412CrossRefPubMedGoogle Scholar
  19. 19.
    Churg A, Vedal S (1994) Fibre burden and patterns of asbestos-related disease in workers with heavy mixed amosite and chrysotile exposure. Am J Respir Crit Care Med 150(3):663–669CrossRefPubMedGoogle Scholar
  20. 20.
    Wagner JC, Skidmore JW (1965) Asbestos dust deposition and retention in rats. Ann NY Acad Sci 132:77–86CrossRefPubMedGoogle Scholar
  21. 21.
    Roggli VL, Pratt PC, Brody AR (1986) Asbestos content of lung tissue in asbestos associated diseases: a study of 110 cases. Br J Ind Med 43(1):18–28PubMedPubMedCentralGoogle Scholar
  22. 22.
    deVuyst P, Asbestosis Genevois PA (2002) In: Hendrick DL, Bruge PS, Beckett WS, Churg A (eds) Occupational disorders of the lung. WB Saunders, London, pp 143–162Google Scholar
  23. 23.
    Kishimoto T, Ohnishi K, Saito Y (2003) Clinical study of asbestos-related lung cancer. Ind Health 41(2):94–100CrossRefPubMedGoogle Scholar
  24. 24.
    Langer AM, Nolan RP (1998) Asbestos in the lungs of persons exposed in the USA. Monaldi Arch Chest Dis 53(2):168–180PubMedGoogle Scholar
  25. 25.
    Sebastien P, Fondimare A, Bignon J, Monchaux G, Desbordes J, Bonnaud G (1975) Topographic distribution of asbestos fibres in human lung in relation to occupational and non-occupational exposure. Inhaled Part 4:435–446PubMedGoogle Scholar
  26. 26.
    Barbieri PG, Mirabelli D, Somigliana A, Cavone D, Merler E (2012) Asbestos fibre burden in the lungs of patients with Mesothelioma who lived near asbestos-cement factories. Ann Occup Hyg 56:660–670PubMedGoogle Scholar
  27. 27.
    Dumortier P, Çoplü P, Broucke I, Emri S, Selcuk T, de Maertelaer V et al (2001) Erionite bodies and fibres in bronchoalveolar lavage fluid (BALF) of residents from Tuzköy, Cappadocia, Turkey. Occup Environ Med 58:261–266CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Langer AM, Nolan RP, Constantopoulos SH, Moutsopoulos HM (1987) Association of Metsovo lung and pleural mesothelioma with exposure to tremolite-containing whitewash. Lancet 1(8539):965–967CrossRefPubMedGoogle Scholar
  29. 29.
    McDonald JC, Armstrong B, Case B, Doell D, McCaughey WTE, McDonald AD et al (1989) Mesothelioma and asbestos fibre type. Evidence from lung tissue analysis. Cancer 63:1544–1547CrossRefPubMedGoogle Scholar
  30. 30.
    Loomis D, Dement JM, Wolf SH, Richardson DB (2009) Lung cancer mortality and fibre exposures among North Carolina asbestos textile workers. Occup Environ Med 13:535–542CrossRefGoogle Scholar
  31. 31.
    Loomis D, Dement J, Richardson D, Wolf S (2010) Asbestos fibre dimensions and lung cancer mortality among workers exposed to chrysotile. Occup Environ Med 13:580–584CrossRefGoogle Scholar
  32. 32.
    Stayner L, Kuempel E, Gilbert S, Hein M, Dement J (2008) An epidemiological study of the role of chrysotile asbestos fibre dimensions in determining respiratory disease risk in exposed workers. Occup Environ Med 13:613–619CrossRefGoogle Scholar
  33. 33.
    Loomis D, Dement JM, Elliott L, Richardson D, Kuempel ED, Stayner L (2012) Increased lung cancer mortality among chrysotile asbestos textile workers is more strongly associated with exposure to long thin fibres. Occup Environ Med 13:564–568CrossRefGoogle Scholar
  34. 34.
    Hamra GB, Loomis D, Dement J (2014) Examining the association of lung cancer and highly correlated fibre size-specific asbestos exposures with a hierarchical Bayesian model. Occup Environ Med 71(5):353–357CrossRefPubMedGoogle Scholar
  35. 35.
    Boulanger G, Andujar P, Pairon JC, Billon-Galland MA, Dion C, Dumortier P et al (2014) Quantification of short and long asbestos fibres to assess asbestos exposure: a review of fibre size toxicity. Environ Health 21(13):59CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Pulmonology DepartmentHospital Universitari Vall d’HebronBarcelonaSpain
  2. 2.Ciber Enfermedades Respiratorias (CibeRes)BarcelonaSpain
  3. 3.Departament de MedicinaUniversitat Autònoma de BarcelonaBarcelonaSpain
  4. 4.Pulmonology Department Hospital Arquitecto MarcideFerrolSpain
  5. 5.Pathology DepartmentHospital Universitario Vall d’HebronBarcelonaSpain

Personalised recommendations